Menu
Back to User profile » Dr Chengguang Zhao
Papers published by Dr Chengguang Zhao:
L61H46 Shows Potent Efficacy Against Human Pancreatic Cancer Through Inhibiting STAT3 Pathway [Erratum]
Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C
Cancer Management and Research 2019, 11:10683-10684
Published Date: 23 December 2019
Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
Zhuang Y, Bai Y, Hu Y, Guo Y, Xu L, Hu W, Yang L, Zhao C, Li X, Zhao H
OncoTargets and Therapy 2019, 12:5281-5291
Published Date: 3 July 2019
L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C
Cancer Management and Research 2018, 10:565-581
Published Date: 23 March 2018
Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells
Zheng HL, Hong H, Zhang LL, Cai X, Hu M, Cai YP, Zhou B, Lin JY, Zhao CG, Hu WL
Cancer Management and Research 2017, 9:565-572
Published Date: 1 November 2017
Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
Shi L, Zheng H, Hu W, Zhou B, Dai X, Zhang Y, Liu Z, Wu X, Zhao C, Liang G
OncoTargets and Therapy 2017, 10:1767-1776
Published Date: 23 March 2017
Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway
Kang Y, Hu W, Bai E, Zheng H, Liu Z, Wu J, Jin R, Zhao C, Liang G
OncoTargets and Therapy 2016, 9:7373-7384
Published Date: 5 December 2016
Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells
Jin R, Xia Y, Chen Q, Li W, Chen D, Ye H, Zhao C, Du X, Shi D, Wu J, Liang G
Drug Design, Development and Therapy 2016, 10:979-995
Published Date: 2 March 2016
Synthesis and biological evaluation of a novel class of curcumin analogs as anti-inflammatory agents for prevention and treatment of sepsis in mouse model
Zhao C, Zhang Y, Zou P, Wang J, He W, Shi D, Li H, Liang G, Yang S
Drug Design, Development and Therapy 2015, 9:1663-1678
Published Date: 18 March 2015
Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents
Zhang Y, Zhao C, He W, Wang Z, Fang Q, Xiao B, Liu Z, Liang G, Yang S
Drug Design, Development and Therapy 2014, 8:373-382
Published Date: 4 April 2014